TransCode Therapeutics ( (RNAZ)) just unveiled an announcement. On December 19, 2025, TransCode Therapeutics appointed veteran life sciences executive Jack E. Stover to its board of directors, ...
BOSTON, Dec. 22, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, ...
The latest round of media company earnings reports confirmed once again that linear TV — cable in particular — is eroding quickly, with its decline in stark contrast with the growing streaming ...
WASHINGTON, Oct 24 (Reuters) - The U.S. will expand the use of facial recognition technology to track non-citizens entering and leaving the country in order to combat visa overstays and passport fraud ...
(RTTNews) - TransCode Therapeutics (RNAZ) has entered into a definitive agreement to acquire Polynoma, a privately-held biotechnology immuno-oncology company. Polynoma is developing a late-stage ...
What happens when a trusted tech brand makes a decision that fundamentally alters how its products are used? For Synology, the answer is unfolding in real-time, as its recent move to eliminate ...
Forever ensnared in a love-fued between 1800s literature and modern gaming, Eman Fatima tries her best to appease both her hobbies by tapping away at her keyboard and writing about her favorite games ...
SAN FRANCISCO, June 10 (Reuters) - Enterprise software maker Linear has raised an $82 million Series C funding round valuing the startup at $1.25 billion, the company said on Tuesday. Venture capital ...
Abstract: Text generation is a compelling sub-field of natural language processing, aiming to generate human-readable text from input words. Although many deep learning models have been proposed, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback